Atlas Trials

Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Sufentanil

Clinical trial NCT04959812 · COMPLETED

Trial details

NCT number
NCT04959812
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Healthy
Start date
2022-03-01
Primary completion
2023-09-08
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.